Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
September 19th, 2022
Imugene to Raise $80 Million
Read More
September 19th, 2022
Cogstate - Investors Await Lecanemab Phase III Data
Read More
September 9th, 2022
Pharmaxis Repurposes PXS-4728 for Parkinson's Disease
Read More
September 9th, 2022
Patrys Passes Final Manufacturing Tests for PAT-DX1
Read More
September 9th, 2022
Anteris Technologies to Present Key Data at TCT this Month
Read More
September 9th, 2022
Patrys Passes Final Manufacturing Tests for PAT-DX1
Read More
August 19th, 2022
Opthea – Novel Funding to Access US$260 Million
Read More
August 19th, 2022
Anteris Technologies to Move to Pivotal Study as Positive Results Continue
Read More
August 5th, 2022
Pharmaxis Sells Orbital Technology for US$5 Million
Read More
August 5th, 2022
Neuren Pharmaceuticals - Partner Files Trofinetide for US Approval
Read More
August 5th, 2022
Imricor - Europe the Key Focus
Read More
August 5th, 2022
Aroa Biosurgery - Cash Receipts up 162% for Quarter to NZ$13.9 Million
Read More
August 5th, 2022
Aroa Biosurgery - Cash Receipts up 162% for Quarter to NZ$13.9 Million
Read More
August 5th, 2022
Cogstate Annual Sales up 74% to US$82.5 Million
Read More
July 5th, 2022
Patrys Meets Manufacturing Yield Milestone for Lead Antibody Candidate
Read More
July 5th, 2022
Imugene Releases Final Survival Data in Phase II Gastric Cancer Study
Read More
June 17th, 2022
Radiopharm Theranostics In-licenses Sixth Technology Program
Read More
June 17th, 2022
Imricor Medical Systems – Pioneering MRI Assisted Cardiac Ablation
Read More
June 17th, 2022
More Important Data for Patrys
Read More
June 3rd, 2022
Radiopharm Theranostics - Six Therapeutic Studies to Commence in 2023
Read More
Pages
1
2
3
4
5
6
7
8
9
